LON:TILSTiziana Life Sciences Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Tiziana Life Sciences PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 157 +7.00 (+4.67 %) (As of 07/16/2020 12:21 PM ET) Add Compare Share Today's Range 148.55Now: GBX 157▼ 16550-Day Range 85MA: GBX 103.64▼ 13952-Week Range 23.50Now: GBX 157▼ 172.50Volume467,628 shsAverage Volume4,999 shsMarket Capitalization£261.26 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInsider TradesHeadlines Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. The company's product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as non-alcoholic steatohepatitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma. It also develops TZLS-501, a human anti-interleukin-6 receptor monoclonal antibody that is in pre-clinical development. The company was founded in 2013 and is headquartered in London, the United Kingdom. Tiziana Life Sciences Plc is a subsidiary of Planwise Group Limited.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Tiziana Life Sciences. Previous Next 1.9 Community Rank Outperform VotesTiziana Life Sciences has received 120 “outperform” votes. (Add your “outperform” vote.)Underperform VotesTiziana Life Sciences has received 202 “underperform” votes. (Add your “underperform” vote.)Community SentimentTiziana Life Sciences has received 62.73% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Tiziana Life Sciences and other stocks. Vote “Outperform” if you believe TILS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TILS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldTiziana Life Sciences does not currently pay a dividend.Dividend GrowthTiziana Life Sciences does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Tiziana Life Sciences insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Tiziana Life Sciences are expected to grow in the coming year, from GBX (2.90) to GBX 0 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tiziana Life Sciences is -23.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tiziana Life Sciences is -23.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.51 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:TILS Previous SymbolLON:ADI CUSIPN/A CIKN/A Webwww.tizianalifesciences.com Phone+44-20-74952379Debt Debt-to-Equity Ratio59.12 Current Ratio0.21 Quick Ratio0.20Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 0.14 per share Price / Cash Flow1,140.00 Book ValueGBX (4) per share Price / Book-39.25Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees10 Outstanding Shares166,408,992Market Cap£261.26 million Next Earnings DateN/A OptionableNot Optionable LSE:TILS Rates by TradingView Receive TILS News and Ratings via Email Sign-up to receive the latest news and ratings for TILS and its competitors with MarketBeat's FREE daily newsletter. Tiziana Life Sciences (LON:TILS) Frequently Asked Questions How has Tiziana Life Sciences' stock been impacted by COVID-19 (Coronavirus)? Tiziana Life Sciences' stock was trading at GBX 85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TILS shares have increased by 84.7% and is now trading at GBX 157. View which stocks have been most impacted by Coronavirus. How were Tiziana Life Sciences' earnings last quarter? Tiziana Life Sciences PLC (LON:TILS) announced its quarterly earnings data on Thursday, June, 18th. The biotechnology company reported ($5.40) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($5.00) by $0.40. View Tiziana Life Sciences' earnings history. Has Tiziana Life Sciences been receiving favorable news coverage? Press coverage about TILS stock has been trending positive this week, InfoTrie reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Tiziana Life Sciences earned a media sentiment score of 2.1 on InfoTrie's scale. They also assigned news articles about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the next several days. View the latest news about Tiziana Life Sciences. Who are some of Tiziana Life Sciences' key competitors? Some companies that are related to Tiziana Life Sciences include Trillium Therapeutics (TRIL), PureTech Health (PRTC), Aptose Biosciences (APS), Oxford BioMedica (OXB), CEL-SCI (CVM), SIGA Technologies (SIGA), Cel-Sci (CVM), Paradigm Biopharmaceuticals (PAR), Altimmune (ALT), Biotest (BIO), iShares Diversified Alternatives Trust (ALT), Neptune Wellness Solutions (NEPT), TELIX Pharmaceutical (TLX), Starpharma (SPL) and Ibio (IBIO). View all competitors. What other stocks do shareholders of Tiziana Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tiziana Life Sciences investors own include Synergy Pharmaceuticals (SGYP), ServiceNow (NOW), Broadcom (AVGO), Dropbox (DBX), Enterprise Products Partners (EPD), Franco Nevada (FNV), Micron Technology (MU), RingCentral (RNG), Tesla (TSLA) and Slack (WORK). Who are Tiziana Life Sciences' key executives? Tiziana Life Sciences' management team includes the following people: Mr. Gabriele Marco Antonio Cerrone M.B.A., MBA, Founder & Exec. Chairman (Age 47)Dr. Kunwar Shailubhai, CEO, Chief Scientific Officer & Exec. Director (Age 61)Dr. Andrea Brancale, Scientific FounderMr. Richard Clarkson Ph.D., Scientific FounderMr. Andrew Westwell Ph.D., Scientific Founder What is Tiziana Life Sciences' stock symbol? Tiziana Life Sciences trades on the London Stock Exchange (LON) under the ticker symbol "TILS." How do I buy shares of Tiziana Life Sciences? Shares of TILS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Tiziana Life Sciences' stock price today? One share of TILS stock can currently be purchased for approximately GBX 157. How big of a company is Tiziana Life Sciences? Tiziana Life Sciences has a market capitalization of £261.26 million. Tiziana Life Sciences employs 10 workers across the globe. What is Tiziana Life Sciences' official website? The official website for Tiziana Life Sciences is www.tizianalifesciences.com. How can I contact Tiziana Life Sciences? Tiziana Life Sciences' mailing address is 3rd Fl, 11-12 St. James's Square, LONDON, SW1Y 4LB, United Kingdom. The biotechnology company can be reached via phone at +44-20-74952379. This page was last updated on 7/16/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
